Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-21

Clinical Trial Update: Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial is evaluating whether ketotifen reduces adverse events during peanut desensitization in children. The study status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketotifen (Ketotifen)

Snippet

Sponsor: Gordon Sussman Clinical Research | Conditions: Peanut Allergies in Children | Phase 2 | Status: UNKNOWN